• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Novel Treatments in Neuroprotection for Aneurysmal Subarachnoid Hemorrhage
Opinion statement New neuroprotective treatments aimed at preventing or minimizing “delayed brain injury” are attractive areas of investigation and hold the potential to have substantial beneficial effects on aneurysmal subarachnoid hemorrhage (aSAH) survivors. The underlying mechanisms for this “delayed brain injury” are multi-factorial and not fully understood. The most ideal treatment strategies would have the potential for a pleotropic effect positively modulating multiple implicated pathophysiological mechanisms at once. My personal management (RFJ) of patients with aneurysmal subarachnoid hemorrhage...
Source: Current Treatment Options in Neurology - June 19, 2016 Category: Neurology Source Type: research

Quality of Care for Patients with TIA with an Eye towards Quality Improvement: How Are We Doing? (P6.036)
Conclusion: Overall, care provided was guideline-concordant, but some patients with TIA are receiving suboptimal care, even among those admitted to a Stroke Center who are routinely admitted or seen by neurology. There are opportunities for improvement in TIA care, especially in statin treatment of eligible TIA patients.Disclosure: Dr. Kalaria has nothing to disclose. Dr. Flair has nothing to disclose. Dr. Cronin has nothing to disclose. Dr. Kittner has nothing to disclose. Dr. Phipps has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Kalaria, C., Flair, Z., Cronin, C., Kittner, S., Phipps, M. Tags: Telestroke and Other Innovations and TIA Source Type: research